If you experience psoriasis alongside overweight or obesity, discussing GLP-1 therapy with your healthcare provider opens the door to potential dual benefits: meaningful weight loss and possibly reduced skin inflammation
You wouldn't leave a high-powered microscope out in the sun or use it as a hammer
Genetic factors influence how your body metabolizes semaglutide and responds to GLP-1 receptor activation
The REDEFINE 3 cardiovascular outcomes trial which will take several years to complete is not a prerequisite for initial market authorisation for obesity treatment, but its results will likely be important for subsequent label expansion and for establishing the cardiovascular benefit profile that has proven so valuable for tirzepatide and semaglutide
When PLOOH is not rapidly neutralized as an PLOH by glutathione peroxidase 4 (GPX4) in time, PLOOH further reacts with ferrous ions, and the resulting lipid radicals, such as alkoxyl phospholipid radicals (PLO) and PLOO, react with PUFA-PLs ( 2 produced by the mitochondrial tricarboxylic acid (TCA) cycle and the reduction of nitrogen oxides by NADPH produce H 2 O 2 catalyzed by superoxide dismutase (SOD) and participate in the Fenton reaction of iron ( Figure 1A )
Lab assessment understand whats going on in your body
